RUMC appoints new hematology/oncology leadership team
Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients ...
Healio3d
Adjuvant regimen extends survival in early HER2-positive breast cancer
Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...
Biomaterial shows potential for treating bone lesions in multiple myeloma
A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...
Developer buys land near Crossgates for regional cancer treatment center
An affiliate of a major developer has bought land near Crossgates where there's a plan to build a regional cancer treatment ...
Red Dye No. 3 banned by FDA; expert discusses risks
The FDA has banned Red Dye No. 3, citing cancer risk concerns. The removal from the supply chain may take over a year, raising questions about other additives.
The American Journal of Managed Care26d
EHA: European Hematology Association
Presentations at the European Hematology Association (EHA) 2024 Congress were encouraging for their data on innovations within the hematology/oncology space that are reshaping treatment outcomes.
Sysmex America Expands Operations with Plans for New Reagent Manufacturing, Distribution and Service Center in Brazil
Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...